Matches in SemOpenAlex for { <https://semopenalex.org/work/W2924012992> ?p ?o ?g. }
- W2924012992 endingPage "648" @default.
- W2924012992 startingPage "637" @default.
- W2924012992 abstract "Abstract Purpose The aim of this study was to determine if there were any differences in health-related outcomes and physical activity (PA) between the two OptiTrain exercise groups and usual care (UC), 2 years post-baseline. Methods The OptiTrain study was a three-arm randomised controlled trial comparing 16 weeks of concurrent aerobic high-intensity interval training (HIIT) and progressive resistance exercise (RT-HIIT) or concurrent HIIT and continuous moderate-intensity aerobic exercise (AT-HIIT) to UC in 206 patients with breast cancer undergoing chemotherapy. Eligible participants were approached 2 years following baseline to assess cancer-related fatigue, quality of life, symptoms, muscle strength, cardiorespiratory fitness, body mass, PA, sedentary behaviour, and sick leave. Results The RT-HIIT group reported lower total cancer-related fatigue, (− 1.37, 95% CI − 2.70, − 0.04, ES = − 0.06) and cognitive cancer-related fatigue (− 1.47, 95% CI − 2.75, − 0.18, ES = − 0.28), and had higher lower limb muscle strength (12.09, 95% CI 3.77, 20.40, ES = 0.52) than UC at 2 years. The AT-HIIT group reported lower total symptoms (− 0.23, 95% CI − 0.42, − 0.03, ES = − 0.15), symptom burden (− 0.30, 95% CI − 0.60, − 0.01, ES = − 0.19), and body mass − 2.15 (− 3.71, − 0.60, ES = − 0.28) than UC at 2 years. Conclusion At 2 years, the exercise groups were generally experiencing positive differences in cancer-related fatigue (RT-HIIT), symptoms (AT-HIIT), and muscle strength (RT-HIIT) to UC. The findings provide novel evidence that being involved in an exercise program during chemotherapy can have long-term benefits for women with breast cancer, but that strategies are needed to create better pathways to support patients to maintain physical activity levels. Trial registration Clinicaltrials.gov registration number: NCT02522260. Trial registered on 9 June 2015. https://clinicaltrials.gov/ct2/show/NCT02522260 . Retrospectively registered." @default.
- W2924012992 created "2019-04-01" @default.
- W2924012992 creator A5006226904 @default.
- W2924012992 creator A5062580246 @default.
- W2924012992 creator A5079735561 @default.
- W2924012992 creator A5082683998 @default.
- W2924012992 date "2019-03-26" @default.
- W2924012992 modified "2023-10-10" @default.
- W2924012992 title "Two-year follow-up of the OptiTrain randomised controlled exercise trial" @default.
- W2924012992 cites W1571594831 @default.
- W2924012992 cites W1891192132 @default.
- W2924012992 cites W1981481816 @default.
- W2924012992 cites W1997449608 @default.
- W2924012992 cites W2010163891 @default.
- W2924012992 cites W2013809936 @default.
- W2924012992 cites W2025371089 @default.
- W2924012992 cites W2040106495 @default.
- W2924012992 cites W2050747757 @default.
- W2924012992 cites W2070956946 @default.
- W2924012992 cites W2087235275 @default.
- W2924012992 cites W2099281324 @default.
- W2924012992 cites W2112395080 @default.
- W2924012992 cites W2145639076 @default.
- W2924012992 cites W2159701602 @default.
- W2924012992 cites W2166444516 @default.
- W2924012992 cites W2167571044 @default.
- W2924012992 cites W2577885843 @default.
- W2924012992 cites W2586935276 @default.
- W2924012992 cites W2608382009 @default.
- W2924012992 cites W2629373459 @default.
- W2924012992 cites W2769880098 @default.
- W2924012992 cites W2788867230 @default.
- W2924012992 cites W2800954604 @default.
- W2924012992 cites W2802859888 @default.
- W2924012992 cites W2805804470 @default.
- W2924012992 cites W2897513125 @default.
- W2924012992 cites W2981414419 @default.
- W2924012992 doi "https://doi.org/10.1007/s10549-019-05204-0" @default.
- W2924012992 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6534518" @default.
- W2924012992 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30915663" @default.
- W2924012992 hasPublicationYear "2019" @default.
- W2924012992 type Work @default.
- W2924012992 sameAs 2924012992 @default.
- W2924012992 citedByCount "30" @default.
- W2924012992 countsByYear W29240129922019 @default.
- W2924012992 countsByYear W29240129922020 @default.
- W2924012992 countsByYear W29240129922021 @default.
- W2924012992 countsByYear W29240129922022 @default.
- W2924012992 countsByYear W29240129922023 @default.
- W2924012992 crossrefType "journal-article" @default.
- W2924012992 hasAuthorship W2924012992A5006226904 @default.
- W2924012992 hasAuthorship W2924012992A5062580246 @default.
- W2924012992 hasAuthorship W2924012992A5079735561 @default.
- W2924012992 hasAuthorship W2924012992A5082683998 @default.
- W2924012992 hasBestOaLocation W29240129921 @default.
- W2924012992 hasConcept C103038586 @default.
- W2924012992 hasConcept C117437137 @default.
- W2924012992 hasConcept C121608353 @default.
- W2924012992 hasConcept C126322002 @default.
- W2924012992 hasConcept C159110408 @default.
- W2924012992 hasConcept C168563851 @default.
- W2924012992 hasConcept C1862650 @default.
- W2924012992 hasConcept C2777973682 @default.
- W2924012992 hasConcept C2778632814 @default.
- W2924012992 hasConcept C2779951463 @default.
- W2924012992 hasConcept C2781444488 @default.
- W2924012992 hasConcept C530470458 @default.
- W2924012992 hasConcept C71924100 @default.
- W2924012992 hasConceptScore W2924012992C103038586 @default.
- W2924012992 hasConceptScore W2924012992C117437137 @default.
- W2924012992 hasConceptScore W2924012992C121608353 @default.
- W2924012992 hasConceptScore W2924012992C126322002 @default.
- W2924012992 hasConceptScore W2924012992C159110408 @default.
- W2924012992 hasConceptScore W2924012992C168563851 @default.
- W2924012992 hasConceptScore W2924012992C1862650 @default.
- W2924012992 hasConceptScore W2924012992C2777973682 @default.
- W2924012992 hasConceptScore W2924012992C2778632814 @default.
- W2924012992 hasConceptScore W2924012992C2779951463 @default.
- W2924012992 hasConceptScore W2924012992C2781444488 @default.
- W2924012992 hasConceptScore W2924012992C530470458 @default.
- W2924012992 hasConceptScore W2924012992C71924100 @default.
- W2924012992 hasFunder F4320321491 @default.
- W2924012992 hasFunder F4320322128 @default.
- W2924012992 hasIssue "3" @default.
- W2924012992 hasLocation W29240129921 @default.
- W2924012992 hasLocation W29240129922 @default.
- W2924012992 hasLocation W29240129923 @default.
- W2924012992 hasLocation W29240129924 @default.
- W2924012992 hasOpenAccess W2924012992 @default.
- W2924012992 hasPrimaryLocation W29240129921 @default.
- W2924012992 hasRelatedWork W2256922103 @default.
- W2924012992 hasRelatedWork W2462924700 @default.
- W2924012992 hasRelatedWork W2534336596 @default.
- W2924012992 hasRelatedWork W2611747044 @default.
- W2924012992 hasRelatedWork W2743737777 @default.
- W2924012992 hasRelatedWork W2788719873 @default.
- W2924012992 hasRelatedWork W2943408935 @default.
- W2924012992 hasRelatedWork W4294862430 @default.